Here's another example of how Jamie Love
"leverages chatter"--takes something meaningless and unimportant,
and then exaggerates it until you'd think it's a major global trend.
Here's a link to an article Jamie wrote for the Financial Express of India, published April 6, 2005.
Notice paragraph 6, where Jamie starts in on H.R. 417 (groan). Toward the end of the paragraph, he says the following:
No it doesn't, Jamie. It does nothing of the sort. All it shows is that there is no law against stupid ideas being written in the form of a bill.
To show that you can radically restructure the entire R&D-based pharmaceutical industry, turn all the incentives on their heads, and still get the desired outputs, you have to do more than just get the goofiest Congressman in the House to introduce a bill.
The fact is, Jamie grossly misrepresents in this article. The U.S. government is NOT "debating whether or not to weaken patent protections on medicines." This is a gross misrepresentation, and it takes advantage of the lack of knowledge that international policy makers have about the fine details of the U.S. legislative process.
It's time that people wise up about Jamie and his distortions. Jamie is constantly taking fringe ideas about IP, or something that only he and a few of his minions are talking about, and then representing to others that these ideas are being taken seriously by policy makers on Capitol Hill. They are not, and Jamie is confusing his own wishful delusions with economic reality.
Jamie's economic systems only work in the utopian fantasyland in his mind. It's the same fantasyland that was in the minds of Lenin, Trotsky, and Mao.
Here's a link to an article Jamie wrote for the Financial Express of India, published April 6, 2005.
Notice paragraph 6, where Jamie starts in on H.R. 417 (groan). Toward the end of the paragraph, he says the following:
"The new US proposal shows one can separate the markets for innovation from that for products providing hefty financial incentives for companies investing in R&D, without harming consumers."
No it doesn't, Jamie. It does nothing of the sort. All it shows is that there is no law against stupid ideas being written in the form of a bill.
To show that you can radically restructure the entire R&D-based pharmaceutical industry, turn all the incentives on their heads, and still get the desired outputs, you have to do more than just get the goofiest Congressman in the House to introduce a bill.
The fact is, Jamie grossly misrepresents in this article. The U.S. government is NOT "debating whether or not to weaken patent protections on medicines." This is a gross misrepresentation, and it takes advantage of the lack of knowledge that international policy makers have about the fine details of the U.S. legislative process.
It's time that people wise up about Jamie and his distortions. Jamie is constantly taking fringe ideas about IP, or something that only he and a few of his minions are talking about, and then representing to others that these ideas are being taken seriously by policy makers on Capitol Hill. They are not, and Jamie is confusing his own wishful delusions with economic reality.
Jamie's economic systems only work in the utopian fantasyland in his mind. It's the same fantasyland that was in the minds of Lenin, Trotsky, and Mao.